Zefamenib, CAS [[2938995-50-5]]

Produktübersicht

• Artikelname: Zefamenib, CAS [[2938995-50-5]]
• Artikelnummer: MCE-HY-153714
• Hersteller Artikelnummer: HY-153714
• Alternativnummer: MCE-HY-153714-25MG,MCE-HY-153714-5MG,MCE-HY-153714-10MG,MCE-HY-153714-50MG,MCE-HY-153714-10MMX1ML,MCE-HY-153714-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BN-104, BNM-1192, Menin-MLL inhibitor 27

Produktbeschreibung

Zefamenib (BN-104) is an effective selective brain membrane protein inhibitor with oral activity, and its also a Menin inhibitor, it can block the Menin-MLL interaction and leads to the degradation of Menin protein. Zefamenib is a weak hERG inhibitor, with an IC50 greater than 100 µM. Zefamenib has anti-tumor activity and can be used in cancer research, such as for acute myeloid leukemia[1].

Produkteigenschaften

• Molekulargewicht: 570.66
• Reinheit: 99.95
• CAS Nummer: [2938995-50-5]
• Formel: C31H35FN8O2
• Target-Kategorie: Epigenetic Reader Domain,Potassium Channel

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound